COVID-19–associated invasive pulmonary aspergillosis (CAPA) is a new entity affecting critically ill COVID-19 patients, which, while not well understood, has announced itself as a serious threat to those suffering with the SARS-CoV-2 infection.
In a small study of patients with CAPA who were hospitalized at the Hospital General Universitario Gregorio Marañón, in Madrid, mortality was 100%, according to a presentation at IDWeek 2020.
“This is a very severe disease,”